array(2) { ["lab"]=> string(4) "1347" ["publication"]=> string(5) "11784" } Dynamically Monitoring the Clonal Evolution of Lung Cancer Based on the Molecular Characterization of Circulating Tumor Cells Using Aptamer Cocktail-Modified Nanosubstrates - 肿瘤精准医学与个性化用药研究团队 | LabXing

肿瘤精准医学与个性化用药研究团队

简介

分享到

Dynamically Monitoring the Clonal Evolution of Lung Cancer Based on the Molecular Characterization of Circulating Tumor Cells Using Aptamer Cocktail-Modified Nanosubstrates

2020
其它